Doximity (DOCS) Stock News

Doximity extended its 13-year partnership with U.S. News & World Report to continue supplying physician data for Best Hospitals rankings, Doctor Finder, and Patient Connect appointment booking. The tools serve over 65 million Americans annually. Doximity remains the exclusive third-party provider of the Expert Opinion physician survey used in the rankings.

A securities fraud class action has been filed against Doximity (DOCS). The lawsuit alleges the company overstated the impact of its Newsfeed on revenue growth and was losing market share to competitors with better pricing and engagement models. The class period covers August 8, 2024 through May 13, 2026. Investors who purchased DOCS common stock during that period may seek lead plaintiff status by November 16, 2026.

Rosen Law Firm reminds Doximity investors of the November 16 lead plaintiff deadline in a securities fraud class action. The lawsuit alleges Doximity overstated Newsfeed revenue impact and lost market share. Class period: August 8, 2024 to May 13, 2026.

Doximity reported Q1 revenue above estimates but EPS, net income, and free cash flow all missed. Q2 revenue guidance came in below consensus, while FY27 revenue guidance edged above.